| Related Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration
Driscoll David F, Deaconess Beth Israel, Lawrence Kenneth R, Lewis Keith, Bistrian Bruce R
|
Mar/Apr 1997
Pg. 118-120
View Sample |
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration
Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
|
Jan/Feb 2009
Pg. 78-80
|
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M, Brown Michael C, Zavala Pedro J
|
Jan/Feb 2018
Pg. 41-46
|
Formulation, Evaluation, and Characterization of Ibuprofen Nanocrystals Tablets with Conventional Market Product
Chauhan Nikita N, Patel Jayvadan K
|
Jan/Feb 2023
Pg. 60-71
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
Allowing Compounding Pharmacies to Address Drug Shortages
Broughel James
|
Mar/Apr 2022
Pg. 100-109
|
PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 92
|
PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again!
Allen Loyd V Jr
|
May/Jun 2023
Pg. 180
|
The Pharmacist Manpower Shortage: How to Recruit and Retain Key Employees
Ashworth Lisa D
|
May/Jun 2001
Pg. 182-184
|
PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 92
|
PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 268
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 350-351
|
PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
|
May/Jun 2013
Pg. 180
|
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis
Lyon Joanna
|
Nov/Dec 2012
Pg. 456-460
|
PreScription: One Size Does Not Fit All!
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 4
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Towards the Importance of a Roller Mill in Compounding Practice: An Experimental Approach
Polonini Hudson, Loures da Silva Sharlene, Batista Patrício Fernando, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
|
Mar/Apr 2019
Pg. 154-156
|
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control
Hutson Chad, Day A J
|
Nov/Dec 2019
Pg. 511-518
|
Best Practices When Compounding FDA-Approved Drugs Listed in Shortage
Alliance for Pharmacy Compounding
|
Jan/Feb 2025
Pg. 22-27
|
Descriptive Report of Individual State Responses to Personal Protective Equipment Shortages for Pharmacy Practice During the Covid-10 Pandemic
Roberts Patricia A, Eberwein Samuel M, Youmans Danielle, Amerine Lindsey B
|
Mar/Apr 2021
Pg. 109-113
|
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients
Moore Renee
|
Sep/Oct 2012
Pg. 394-395
|
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
|
May/Jun 2010
Pg. 250-256
|
Considerations for Percutaneous Absorption
Newton Stephen J, Cook Jennifer M
|
Jul/Aug 2010
Pg. 301-304
|
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
|
Mar/Apr 2017
Pg. 105-108
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations
Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J
|
May/Jun 2018
Pg. 247-251
|
Mixing in a Compounding Pharmacy in the 21st Century
Standridge Rob
|
Nov/Dec 2015
Pg. 479-484
|
Stability of Suspensions: Theoretical and Practical Considerations before Compounding
Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
|
Jan/Feb 2015
Pg. 78-85
|
Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
|
May/Jun 2021
Pg. 218-221
|
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 34-38
|
Design and Development of Agglomerated Isomalt
Chauhan Nikita N, Patel Jayvadan K
|
Jan/Feb 2023
Pg. 78-87
|
Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 295-302
|
Basics of Sterile Compounding: Particulate Matter
Akers Michael J
|
Sep/Oct 2017
Pg. 395-404
|
Particulates in Parenterals
Allen Loyd V Jr
|
Jan/Feb 2000
Pg. 43
|
Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions
Al-Achi Antoine, Siddoju Srujana
|
May/Jun 2005
Pg. 207
|
Physical Assessments of Lipid Injectable Emulsions via Microscopy: A Comparison to Methods Proposed in the United States Pharmacopeia Chapter <729>
Driscoll David F, Nehne Jorg, Horst Peterss, Klutsch Karsten, Bistrian Bruce R, Wilhelm Niemann
|
Jul/Aug 2006
Pg. 309-315
|
Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating
Martin Matt
|
Jul/Aug 2018
Pg. 303-312
|
Compounding Metformin for Use in Functional Medicine
Desai Sarina, Thompson Tara
|
Sep/Oct 2023
Pg. 362-366
|
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
|
Jan/Feb 2023
Pg. 22-23
|
Three Things You Need to Know Right Now
Brunner Scott
|
May/Jun 2022
Pg. 211-213
|
Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding
Mulder Kyle
|
May/Jun 2021
Pg. 211-216
|
Sterile Filtration
Akers Michael J
|
Mar/Apr 2024
Pg. 120-127
|
Certification of Powder-containment Hoods for Nonsterile Compounding
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018
Pg. 369-384
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Mulder Kyle
|
Jan/Feb 2020
Pg. 7-12
|
Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding
Ligugnana Roberto
|
May/Jun 2017
Pg. 182-190
|
Microbiologic Testing for 503A Sterile-Compounding Pharmacies
Mixon William, Roth Abby
|
May/Jun 2017
Pg. 193-203
|
Basics of Sterile Compounding: Manipulating Peptides and Proteins
Akers Michael J
|
May/Jun 2017
Pg. 223-228
|
Basics of Sterile Compounding: Contamination Control
Akers Michael J
|
May/Jun 2015
Pg. 232-238
|
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration
Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
|
Jan/Feb 2015
Pg. 70-72
|
Sterile Filtration
Akers Michael J
|
Sep/Oct 2015
Pg. 393-401
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding
Akers Michael J
|
Jul/Aug 2016
Pg. 307-314
|
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C, Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 322-329
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
PreScription: Challenging Times
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 268
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
In the Hands of Your Enemy
Worthen Dennis B
|
Nov/Dec 2010
Pg. 456-462
|
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 490-496
|
Buffered Aspirin Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 228
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Ethambutol 400-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 231
|
Isoniazid 300-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 232
|
Labetalol 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 233
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 235
|
Prednisone 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 236
|
Reserpine 0.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 237
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
|
Jul/Aug 2010
Pg. 270-274
|
Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!"
McElhiney Linda F
|
Jan/Feb 2009
Pg. 20-25
|
The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding
Conroy Mary Schaeffer
|
Mar/Apr 2011
Pg. 117-122
|
PreScription: American Pharmacists Month: A Time for Taking Responsibility
Menighan Thomas E
|
Sep/Oct 2011
Pg. 356
|
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David
|
Sep/Oct 2011
Pg. 382-384
|
The International Academy of Compounding Pharmacists Debuts the Compounding Pharmacy Assessment Questionnaire
Miller David G
|
Nov/Dec 2011
Pg. 474-479
View Sample |
PreScription: Working in Handcuffs
Menighan Thomas E
|
May/Jun 2012
Pg. 180
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Benzonatate 100-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 326
|
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
|
Sep/Oct 2015
Pg. 377-380
|
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 504
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Propranolol Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 513
|
Sodium Phosphate Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 413
|
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias, Tal Yana, Amarny Kamal
|
Sep/Oct 2016
Pg. 438-439
|
PreScription: COVID-19 and Compounding Pharmacists
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 268
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
A Permanent Path for Urgent-use Compounding? APC-supported Legislation Would Allow 503As to Fill Gaps in Coverage When 503Bs Cannot
Brunner Scott
|
Jul/Aug 2021
Pg. 296-297
|
Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 24-28
|
Everything Old is New Again
Brunner Scott
|
Jan/Feb 2022
Pg. 30-32
|
PreScription: Standing in the Gap
Allen Loyd V Jr
|
May/Jun 2022
Pg. 180
|
| Return to Top |
